Literature DB >> 8443411

Phosphorylation independent activation of human cyclin-dependent kinase 2 by cyclin A in vitro.

L Connell-Crowley1, M J Solomon, N Wei, J W Harper.   

Abstract

p33cdk2 is a serine-threonine protein kinase that associates with cyclins A, D, and E and has been implicated in the control of the G1/S transition in mammalian cells. Recent evidence indicates that cyclin-dependent kinase 2 (Cdk2), like its homolog Cdc2, requires cyclin binding and phosphorylation (of threonine-160) for activation in vivo. However, the extent to which mechanistic details of the activation process are conserved between Cdc2 and Cdk2 is unknown. We have developed bacterial expression and purification systems for Cdk2 and cyclin A that allow mechanistic studies of the activation process to be performed in the absence of cell extracts. Recombinant Cdk2 is essentially inactive as a histone H1 kinase (< 4 x 10(-5) pmol phosphate transferred.min-1 x microgram-1 Cdk2). However, in the presence of equimolar cyclin A, the specific activity is approximately 16 pmol.mon-1 x microgram-1, 4 x 10(5)-fold higher than Cdk2 alone. Mutation of T160 in Cdk2 to either alanine or glutamic acid had little impact on the specific activity of the Cdk2/cyclin A complex: the activity of Cdk2T160E was indistinguishable from Cdk2, whereas that of Cdk2T160A was reduced by five-fold. To determine if the Cdk2/cyclin A complex could be activated further by phosphorylation of T160, complexes were treated with Cdc2 activating kinase (CAK), purified approximately 12,000-fold from Xenopus eggs. This treatment resulted in an 80-fold increase in specific activity. This specific activity is comparable with that of the Cdc2/cyclin B complex after complete activation by CAK (approximately 1600 pmol.mon-1 x microgram-1). Neither Cdk2T160A/cyclin A nor Cdk2T160E/cyclin A complexes were activated further by treatment with CAK. In striking contrast with cyclin A, cyclin B did not directly activate Cdk2. However, both Cdk2/cyclin A and Cdk2/cyclin B complexes display similar activity after activation by CAK. For the Cdk2/cyclin A complex, both cyclin binding and phosphorylation contribute significantly to activation, although the energetic contribution of cyclin A binding is greater than that of T160 phosphorylation by approximately 5 kcal/mol. The potential significance of direct activation of Cdk2 by cyclins with respect to regulation of cell cycle progression is discussed.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8443411      PMCID: PMC300902          DOI: 10.1091/mbc.4.1.79

Source DB:  PubMed          Journal:  Mol Biol Cell        ISSN: 1059-1524            Impact factor:   4.138


  62 in total

Review 1.  p34cdc2: the S and M kinase?

Authors:  J Pines; T Hunter
Journal:  New Biol       Date:  1990-05

2.  Cloning by differential screening of a Xenopus cDNA coding for a protein highly homologous to cdc2.

Authors:  J Paris; R Le Guellec; A Couturier; K Le Guellec; F Omilli; J Camonis; S MacNeill; M Philippe
Journal:  Proc Natl Acad Sci U S A       Date:  1991-02-01       Impact factor: 11.205

3.  Cyclin activation of p34cdc2.

Authors:  M J Solomon; M Glotzer; T H Lee; M Philippe; M W Kirschner
Journal:  Cell       Date:  1990-11-30       Impact factor: 41.582

4.  The role of CDC28 and cyclins during mitosis in the budding yeast S. cerevisiae.

Authors:  U Surana; H Robitsch; C Price; T Schuster; I Fitch; A B Futcher; K Nasmyth
Journal:  Cell       Date:  1991-04-05       Impact factor: 41.582

5.  A cyclin B homolog in S. cerevisiae: chronic activation of the Cdc28 protein kinase by cyclin prevents exit from mitosis.

Authors:  J B Ghiara; H E Richardson; K Sugimoto; M Henze; D J Lew; C Wittenberg; S I Reed
Journal:  Cell       Date:  1991-04-05       Impact factor: 41.582

6.  Inactivation of the p34cdc2-cyclin B complex by the human WEE1 tyrosine kinase.

Authors:  L L Parker; H Piwnica-Worms
Journal:  Science       Date:  1992-09-25       Impact factor: 47.728

7.  The cdc25 protein controls tyrosine dephosphorylation of the cdc2 protein in a cell-free system.

Authors:  A Kumagai; W G Dunphy
Journal:  Cell       Date:  1991-03-08       Impact factor: 41.582

8.  Differential phosphorylation of vertebrate p34cdc2 kinase at the G1/S and G2/M transitions of the cell cycle: identification of major phosphorylation sites.

Authors:  W Krek; E A Nigg
Journal:  EMBO J       Date:  1991-02       Impact factor: 11.598

9.  Cyclin promotes the tyrosine phosphorylation of p34cdc2 in a wee1+ dependent manner.

Authors:  L L Parker; S Atherton-Fessler; M S Lee; S Ogg; J L Falk; K I Swenson; H Piwnica-Worms
Journal:  EMBO J       Date:  1991-05       Impact factor: 11.598

10.  Activation of p34cdc2 kinase by cyclin A.

Authors:  L M Roy; K I Swenson; D H Walker; B G Gabrielli; R S Li; H Piwnica-Worms; J L Maller
Journal:  J Cell Biol       Date:  1991-05       Impact factor: 10.539

View more
  55 in total

1.  CAK-independent activation of CDK6 by a viral cyclin.

Authors:  P Kaldis; P M Ojala; L Tong; T P Mäkelä; M J Solomon
Journal:  Mol Biol Cell       Date:  2001-12       Impact factor: 4.138

2.  The Schizosaccharomyces pombe spindle checkpoint protein mad2p blocks anaphase and genetically interacts with the anaphase-promoting complex.

Authors:  X He; T E Patterson; S Sazer
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-22       Impact factor: 11.205

3.  Interactions between the nitrogen signal transduction protein PII and N-acetyl glutamate kinase in organisms that perform oxygenic photosynthesis.

Authors:  Sergio Burillo; Ignacio Luque; Inmaculada Fuentes; Asunción Contreras
Journal:  J Bacteriol       Date:  2004-06       Impact factor: 3.490

4.  Isolation and characterization of two human transcription factor IIH (TFIIH)-related complexes: ERCC2/CAK and TFIIH.

Authors:  J T Reardon; H Ge; E Gibbs; A Sancar; J Hurwitz; Z Q Pan
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-25       Impact factor: 11.205

5.  Recombinant Leishmania mexicana CRK3:CYCA has protein kinase activity in the absence of phosphorylation on the T-loop residue Thr178.

Authors:  Felipe C Gomes; Nahla Osman M Ali; Elaine Brown; Roderick G Walker; Karen M Grant; Jeremy C Mottram
Journal:  Mol Biochem Parasitol       Date:  2010-03-23       Impact factor: 1.759

6.  Mechanistic studies of the mitotic activation of Mos.

Authors:  Jianbo Yue; James E Ferrell
Journal:  Mol Cell Biol       Date:  2006-07       Impact factor: 4.272

7.  Cyclin A/CDK2 binds directly to E2F-1 and inhibits the DNA-binding activity of E2F-1/DP-1 by phosphorylation.

Authors:  M Xu; K A Sheppard; C Y Peng; A S Yee; H Piwnica-Worms
Journal:  Mol Cell Biol       Date:  1994-12       Impact factor: 4.272

8.  Human and yeast cdk-activating kinases (CAKs) display distinct substrate specificities.

Authors:  P Kaldis; A A Russo; H S Chou; N P Pavletich; M J Solomon
Journal:  Mol Biol Cell       Date:  1998-09       Impact factor: 4.138

9.  Expression and activity of p40MO15, the catalytic subunit of cdk-activating kinase, during Xenopus oogenesis and embryogenesis.

Authors:  A J Brown; T Jones; J Shuttleworth
Journal:  Mol Biol Cell       Date:  1994-08       Impact factor: 4.138

10.  An investigation of the role of Glu-842, Glu-844 and His-846 in the function of the cytoplasmic domain of the epidermal growth factor receptor.

Authors:  J F Timms; M E Noble; M Gregoriou
Journal:  Biochem J       Date:  1995-05-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.